LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with ...

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its ...

The studies compared the Unity Vitreoretinal Cataract System (VCS) to the Constellation Vision System and the ...

In conjunction with the definitive proxy filing, Staar (STAA) is mailing the following letter to Staar stockholders: “On August 5, 2025, we ...

Alcon (NYSE: ALC) shares registered just barely in the plus column Tuesday. The company, purporting to be the global leader in eye care dedicated to helping people see brilliantly, announced results ...

Alcon (ALC) announced results from time and motion studies demonstrating efficiency with Unity Vitreoretinal Cataract System for vitreoretinal and ...

Alcon launched wavelight plus, a personalized LASIK treatment, in the U.S. and Canada, according to a press release.

Broadwood Partners said today that it intends to vote against the proposed acquisition of Staar Surgical (Nasdaq:STAA) by Alcon (NYSE:ALC).

Part of Alcon's motivations for continuing to pursue the lawsuit relates to an upcoming TV series based on the movie. The company expressed that it wants to distance itself from Tesla and Elon Musk.